lunes, 23 de septiembre de 2019

Failure to administer recommended chemotherapy: acceptable variation or cancer care quality blind spot? | AHRQ Patient Safety Network

Failure to administer recommended chemotherapy: acceptable variation or cancer care quality blind spot? | AHRQ Patient Safety Network

PSNet email header

  • Study
  •  
  • Published July 2019

Failure to administer recommended chemotherapy: acceptable variation or cancer care quality blind spot?

    This retrospective study of cancer care safety examined the extent to which patients received recommended chemotherapy. A significant proportion of breast, lung, and colorectal cancer patients did not receive chemotherapy; patients who were black and those lacking health insurance or covered by Medicaid were at higher risk. There was marked variability in chemotherapy delivery by location and hospital. The authors conclude that failure to administer chemotherapy is a significant safety gap that should be addressed.














    View More

    No hay comentarios: